Viewing Study NCT01266902


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-05-27 @ 4:15 AM
Study NCT ID: NCT01266902
Status: COMPLETED
Last Update Posted: 2021-03-04
First Post: 2010-12-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1
Sponsor: Janssen R&D Ireland
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR017434
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators